We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$475M
AUM Growth
+$179M
Cap. Flow
+$143M
Cap. Flow %
30.15%
Top 10 Hldgs %
76.93%
Holding
46
New
12
Increased
12
Reduced
9
Closed
12

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$43.6M
2
CRH icon
CRH
CRH
+$34.5M
3
LIN icon
Linde
LIN
+$22.3M
4
AMZN icon
Amazon
AMZN
+$17.4M
5
NFLX icon
Netflix
NFLX
+$16.5M

Sector Composition

Rank Sector Weight
1 Materials 30.28%
2 Consumer Discretionary 19.4%
3 Financials 17.36%
4 Technology 15.26%
5 Communication Services 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCOR icon
26
Procore
PCOR
$7.43B
$711K 0.15%
8,320
-300
-3% -$22.2K
INTU icon
27
Intuit
INTU
$89.6B
$690K 0.15%
887
CFLT
28
DELISTED
Confluent
CFLT
$489K 0.1%
13,780
-205,874
-94% -$5.05M
LOGI icon
29
Logitech
LOGI
$15.2B
$333K 0.07%
3,478
+1,639
+89% +$184K
TTE icon
30
TotalEnergies
TTE
$192B
$269K 0.06%
+4,127
New +$261K
JPM icon
31
JPMorgan Chase
JPM
$929B
$30.3K 0.01%
80
-91,794
-100% -$28.4M
PNC icon
32
PNC Financial Services
PNC
$100B
$14K ﹤0.01%
57
-140,133
-100% -$27M
SNPS icon
33
Synopsys
SNPS
$72.5B
$13.8K ﹤0.01%
25
-8,207
-100% -$3.65M
APGE icon
34
Apogee Therapeutics
APGE
$10.1B
$4.61K ﹤0.01%
52
-51,491
-100% -$3.24M
ABBV icon
35
AbbVie
ABBV
$471B
-103
Closed -$28K
ALC icon
36
Alcon
ALC
$33.9B
-1,499
Closed -$104K
BSX icon
37
Boston Scientific
BSX
$68.1B
-79,463
Closed -$9.12M
CCEP icon
38
Coca-Cola Europacific Partners
CCEP
$48.9B
-171,513
Closed -$15.5M
DB icon
39
Deutsche Bank
DB
$68.8B
-2,318
Closed -$81.6K
DDOG icon
40
Datadog
DDOG
$90.7B
-57
Closed -$9.54K
HUBS icon
41
HubSpot
HUBS
$12.7B
-64
Closed -$35.2K
LLY icon
42
Eli Lilly
LLY
$1.09T
-100
Closed -$89.7K
ORCL icon
43
Oracle
ORCL
$339B
-15
Closed -$4.96K
PFE icon
44
Pfizer
PFE
$144B
-12,821
Closed -$384K
VRTX icon
45
Vertex Pharmaceuticals
VRTX
$124B
-100
Closed -$46K
ZS icon
46
Zscaler
ZS
$24.8B
-100
Closed -$35.2K

Similar funds

Exane Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Exane Asset Management held 46 positions worth $475M, up 60% from $297M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Exane Asset Management deployed $143M of net new capital in Q4 2025, opening 12 new positions and adding to 12 existing holdings. Its largest new stake was Linde: 52,057 shares worth $26.1M.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $28.4M trimmed.

  • Exane Asset Management's largest Q4 2025 buy was Linde: 52,057 shares worth $26.1M.
  • Exane Asset Management added most to Bank of America in Q4 2025, an estimated $43.6M increase.
  • Exane Asset Management's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $28.4M.
  • Exane Asset Management fully exited Coca-Cola Europacific Partners in Q4 2025, selling an estimated $15.5M.
  • Exane Asset Management's ten largest holdings make up 77% of its $475M portfolio in Q4 2025.
  • Exane Asset Management opened 12 new positions and closed 12 in Q4 2025.
  • Exane Asset Management's portfolio value rose 60% quarter-over-quarter to $475M.

Based on Exane Asset Management's 13F filing for Q4 2025, filed 27 Jan 2026.